NMLSF Stock Price, Chart, Stats & News

Restart Life Sciences Corp.
Save
Restart Life Sciences Corp. (NMLSF) does not currently pay a dividend.
2.15M
Market cap
–
Current P/E
–
Forward P/E
NMLSF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company worldwide. It engages in developing natural remedies specifically tailored for individuals on the autism spectrum; health-related foods that promote both mind and body wellness for healthy living, as well as psilocybin clinical trial for fragile X syndrome. The company has collaboration with the University of Manitoba's Richardson Centre for food technology and research (RCFTR) to support a series of food-related scientific studies.
Similar securities
Based on sector and market capitalization
Report issue





